Attitudes and Knowledge of Acne in Mexican Adolescents

December 1, 2014 updated by: Juan Pablo Castanedo-Cazares, Universidad Autonoma de San Luis Potosí

Survey About Knowledge and Attitudes Regarding Acne in Mexican Adolescents

Acne is a chronic inflammatory disease that affects almost 100% of the teenagers worldwide. The peak incidence is between 12 and 18 years old, although it can be present in adults. There are many different beliefs about what can cause or exacerbate acne, and also about treatment.

In Mexico, 26.4% of the population is between 15 and 29 years old, which represents that more than 25% of the population is at risk for presenting acne. In our country, the different beliefs about the causes and treatment of acne among general adolescent population have not been explored. The objective of the present study is to determine the possible causes for which young Mexicans do not go to the dermatologist to receive treatment for acne. Our main hypothesis is that the lack of knowledge of the disease is responsible for this behavior.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Acne is a chronic inflammatory disease that affects almost 100% of the teenagers worldwide. The peak incidence is between 12 and 18 years old, although it can be present in adults. There are many different beliefs about what factors can cause or exacerbate acne, as well concerning treatments.

In Mexico, 26.4% of the population is between 15 and 29 years old, which represents that more than 25% of the population is at risk for presenting acne. In our country, there are diverse beliefs about the causes and treatment of acne among general adolescent population which have not been explored before. The objective of the present study is to determine possible causes that are involved in the low use of health system with the intention to receive treatment for acne. The investigators' main hypothesis is that the lack of knowledge of the disease is responsible for this behavior.

The investigators are going to explore health, educational, family and economic issues in the search of association by multivariate analysis.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SLP
      • San Luis Potosi, SLP, Mexico, 78210
        • Recruiting
        • Hospital Central Dr. Ignacio Morones Prieto
        • Contact:
        • Sub-Investigator:
          • Adriana Ehnis-Perez, MD
        • Principal Investigator:
          • Juan P Castanedo-Cazares, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 25 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Community high schools and colleges.

Description

Inclusion Criteria:

  • Mexican subjects
  • Age between 12 and 25 years
  • Both genders
  • Sign informed consent

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adolescents
Acne survey among Mexican adolescents
A survey is directly applied to subjects who meet the inclusion and exclusion criteria

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cause for not receiving medical treatment
Time Frame: Up to 1 year
To determine the possible causes for which an adolescent does not look for medical treatment for acne
Up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of knowledge about acne
Time Frame: Up to 1 year
To describe the knowledge that young subjects have regarding the causes of acne
Up to 1 year
Treatments for acne used by teenagers
Time Frame: Up to 1 year
To describe the most used treatments for acne among teenagers
Up to 1 year
Professional indicated to treat acne
Time Frame: Up to 1 year
To know which professionals (health-care related or not) are considered appropriate by teenagers to treat acne
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Bertha Torres-Alvarez, MD, Universidad Autonoma de San Luis Potosí

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (ANTICIPATED)

January 1, 2015

Study Completion (ANTICIPATED)

March 1, 2015

Study Registration Dates

First Submitted

May 16, 2013

First Submitted That Met QC Criteria

May 17, 2013

First Posted (ESTIMATE)

May 20, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

December 2, 2014

Last Update Submitted That Met QC Criteria

December 1, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • AcKNOW

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acne

Clinical Trials on Survey

3
Subscribe